Ultragenyx Pharma (RARE) PT Lowered to $43 at Guggenheim
Guggenheim analyst Debjit Chattopadhyay lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
